Most children having cancer treatment have a central line: a tube that comes out through the skin of the chest, or a port under the skin. The care is mostly about preventing infection: clean hands, scrubbing the end of the line before every use, a clean secure dressing, and keeping the line out of water. Families are asked to ring their unit for a temperature of 38°C or above.
No current graded guideline covers central line care in children with cancer as its own subject. The Children's Oncology Group endorsed a 2013 guideline on central venous catheter care for patients with cancer in October 2016 and archived that endorsement in August 2018; the Italian paediatric haematology and oncology association published guidelines in 2022 that could be read only as an abstract; epic3 states that it does not address children having chemotherapy through long-term catheters. What can be read is the UK Children's Cancer and Leukaemia Group (CCLG) resource for community teams (updated January 2026), the general CDC/HICPAC (2011, updated 2017) and SHEA (2022) guidelines where they speak of children, and the Children's Hospital Association (CHA) maintenance bundle with its outcome studies. Each child's own treatment centre has a line policy, and that policy comes first; this page explains the care and is not a guide to doing it.
The care itself: trained staff and trained families only (CCLG; SHEA asks for patient and family education before transfer home); hand hygiene (CDC Category IB) and aseptic non-touch technique; the cap or hub scrubbed before every entry (SHEA at least 5 seconds; epic3 at least 15 seconds and allowed to dry; the CHA bundle 15 seconds of alcohol scrub and 15 seconds to dry, or 30 seconds of chlorhexidine and 30 to 60 seconds to dry); the site cleaned with chlorhexidine in alcohol (CDC above 0.5%; epic3 2% in 70% isopropyl alcohol) and re-dressed weekly while it needs a dressing, with the line looped and taped or kept in a bag; sodium chloride flushes from a 10 ml or larger syringe; a port needle placed after numbing cream and changed within two weeks (CCLG) or every 7 days (CHA bundle). The CHA bundle also asks for sterile gloves and a mask for whoever changes a dressing or a port needle, and for the child's face to be shielded from the site.
Where children differ from adults. Chlorhexidine: CDC makes no recommendation on its safety or efficacy in infants under 2 months; its 2017 update makes no recommendation on chlorhexidine dressings for short-term, non-tunnelled lines in anyone under 18 and recommends against them in premature neonates; SHEA recommends chlorhexidine dressings from 2 months of age. Chlorhexidine bathing: a Children's Oncology Group randomised trial in 177 children did not support it. Locks: CCLG says most UK centres now lock with saline; a Cochrane review (4 trials, 255 children) could not tell saline from heparin, and describes typical heparin locks of 10 units per ml for tunnelled lines and 100 units per ml for ports. No guideline read sets a heparin concentration or a flush volume for children. Ethanol locks prevented infection in one trial of 307 children and increased blockage without benefit in another of 94; taurolidine locks cut infection in a trial of 112 children and made no detectable difference in one of 463. Swimming: CCLG says not with a tunnelled line, and yes with a port that has no needle in it when the child is not neutropenic. Fever: CCLG says families are advised to telephone the unit for a temperature of 38°C or above on one occasion, even if the child seems well.
The bundle works when everyone who touches the line is in it. In one centre, training and auditing clinic nurses, home-care nurses and families together was followed by a fall in line infections in children at home from 0.63 to 0.32 per 1,000 line days.
Why: A central line ends in a large vein near the heart. CCLG lists poor line management among the causes of infection, and handling faults among the causes of damage to the line, so the handling is taught and checked first.
“Before caring for these lines, training must have been completed and CVAD competencies achieved.”
Why: Children with cancer are often looked after as outpatients with the line in place, and at home a parent or the young person may be the one flushing the line or changing the dressing. In a survey of 105 patients and carers at one United States clinic, 23% said they had no training before first going home with a line.
“In addition, education of the patient and/or family, as appropriate, is required for all CVC care procedures especially when transfer to an alternative setting (eg, home care, ambulatory setting) is planned.”
SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022
Why: Clean hands, together with aseptic technique whenever the line is handled, protect against line infection.
“Hand hygiene should be performed before and after palpating catheter insertion sites as well as before and after inserting, replacing, accessing, repairing, or dressing an intravascular catheter.”
CDC/HICPAC 2011 · Category IB
Why: CCLG puts this first among its principles of line care: it is how infection is kept out each time the line is handled.
“To prevent infection adhering to principles of (Aseptic) Non-Touch Technique (A) NTT.”
Why: SHEA notes that about half of hubs and connectors carry germs in ordinary practice, and scrubbing lowers the number carried into the line. The sources set different times: SHEA at least 5 seconds; epic3 at least 15 seconds, then left to dry; the children's hospital bundle 15 seconds of alcohol and 15 seconds to dry, or 30 seconds of chlorhexidine and 30 to 60 seconds to dry.
“Disinfect catheter hubs, needleless connectors, and injection ports before accessing the catheter (Quality of Evidence: MODERATE)”
SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 · Quality of Evidence: MODERATE
Why: CCLG lists redness, swelling, pain, fever and discharge at the exit site as the signs of a line infection. Regular checks are how they are noticed.
“Monitor the catheter sites visually when changing the dressing or by palpation through an intact dressing on a regular basis, depending on the clinical situation of the individual patient.”
CDC/HICPAC 2011 · Category IB
Why: Chlorhexidine in alcohol carries CDC's strongest grade for line sites (above 0.5%; epic3 asks for 2% in 70% isopropyl alcohol, left to air dry). SHEA reports serious skin injuries from chlorhexidine in very young or very preterm babies, and CDC makes no recommendation on it under 2 months.
“Prepare clean skin with a >0.5% chlorhexidine preparation with alcohol before central venous catheter and peripheral arterial catheter insertion and during dressing changes.”
CDC/HICPAC 2011 · Category IA
Why: A new exit site is kept under a clear dressing. CCLG and epic3 both say a dressing may no longer be needed once the site has healed, and CDC asks for any dressing that is damp, loosened or visibly soiled to be replaced.
“When the exit site is clean and dry it should be cleaned and re-dressed weekly, if it requires a dressing.”
Why: CCLG gives the reasons: securing the line prevents pulling, discomfort and tugging on the exit site, and a line kept in a bag or taped in a loop is less likely to be pulled out by accident.
“Long term lines that are well healed do not require dressing but must be secured.”
Why: CCLG names correct flushing as the way to prevent a blocked line, and tells teams to avoid small syringes wherever possible to prevent damage to the line.
“The line requires flushing with sodium chloride.”
Why: A port needs a needle through the skin each time. CCLG says a local anaesthetic cream can be used first, that play specialists are available in hospital to prepare the child, and that the port is accessed with a special non-coring needle.
“Before inserting the gripper™ needle a local anaesthetic cream can be used.”
Why: CCLG says a port with no needle in it needs no other care. One of its three principles of line care is to keep the device open.
“When the Portacath™ is not in use, no particular care is required and it only needs to be flushed monthly.”
Why: CDC allows showering if the line and its connector are protected with an impermeable cover, to make it less likely that germs get into the line. CCLG says children with a tunnelled line must bathe with care and that showers are more advisable.
“Do not submerge the catheter or catheter site in water.”
CDC/HICPAC 2011 · Category IB
Why: With no needle in, a port lies wholly under the skin, and CCLG says the child may swim and bathe; it asks only that contact sports be avoided.
“When there is no gripper needle in the Portacath™ they may go swimming (if not neutropenic), bathe, etc, although contact sports should be avoided.”
Why: A line that will not bleed back may have moved or have a clot or a fibrin sheath at its tip, so it is checked by X-ray or venogram and the result written in the notes before it is used.
“Chemotherapy should NEVER be administered in a line with PWO until the line has been checked by x-ray or venogram for position or signs of a blood clot or fibrin sheath at the end of the line.”
Why: CCLG's reason for the clamp is to prevent bleeding; it also lists a line open to the air as a cause of air getting into the blood. It says repair is possible only for the outside part of a line, by a trained practitioner.
“Clamp line above break to prevent bleeding.”
Why: CDC asks teams to encourage this, and CCLG calls the education of the patient and parent key to preventing line infection.
“Encourage patients to report any changes in their catheter site or any new discomfort to their provider.”
CDC/HICPAC 2011 · Category II
Why: CCLG tells community teams to treat any fever as a sign of infection until proven otherwise, and lists a central line among the things that raise the risk. It says an unwell child with a fever and low immunity may get worse quickly, and that families can call 999 at any point on the way to hospital.
“They are also instructed to contact the hospital if their child appears unwell, regardless of fever, and community professionals should note that low temperature may be a later sign of sepsis.”
Why: The line is handled by many people in many places. In the centre that did this, line infections in children living at home fell by about half.
“The mean CLABSI rate decreased by 48% from 0.63 CLABSIs per 1000 central line days at baseline to 0.32 CLABSIs per 1000 central line days during the intervention period (P = .005).”
Pediatrics (Rinke et al.) 2013 · Interrupted time-series study, one centre
Why: CCLG gives the reason: to prevent the risk of infection.
“All devices are recommended to be removed as soon as possible, when intensive treatment finishes, to prevent risk of infection.”
How care is usually carried out, read from the guidelines and standards cited. Your own team's protocol and their judgement come first; this page is for understanding it, not for doing it yourself.
No current graded guideline on central line care in children with cancer could be read, so best in class is assembled from three kinds of source and the differences are shown. The Children's Hospital Association bundle is the paediatric oncology approach with outcome data. It covers three areas: fewer entries into the line (a daily review of whether the line is needed), aseptic entries (hand hygiene, gloves, and the cap scrubbed with alcohol for 15 seconds and dried for 15, or with chlorhexidine for 30 seconds and dried for 30 to 60), and aseptic changes of caps, tubing, dressings and port needles (sterile gloves and a mask for the person doing it, the site scrubbed with chlorhexidine, and the child's face shielded during dressing and port needle changes), with clear dressings and port needles changed every 7 days and gauze dressings every 2. Its authors mark most elements as CDC recommendations and the rest as the association's expert consensus. Across 32 units the infection rate fell from 2.85 to 2.04 per 1,000 line days (Bundy 2014); in one inpatient unit from 2.25 to 1.79, a change that was not statistically significant (Rinke 2012); and in one centre's children at home from 0.63 to 0.32 (Rinke 2013). The CCLG resource (UK, January 2026) adds the home side: weekly dressing while one is needed, a secured line, saline flushes and saline locks, monthly port flushes, no swimming with a tunnelled line. The general guidelines grade the shared steps (CDC Category IA for chlorhexidine in alcohol, IB for hand hygiene and for not submerging the line). The sources differ on five points. Chlorhexidine dressings: SHEA 2022 recommends them from 2 months of age (quality of evidence high), CDC's 2017 update makes no recommendation under 18 years for short-term, non-tunnelled lines, and CCLG reports that many UK centres use them. Hub scrub time: SHEA at least 5 seconds, epic3 at least 15, the bundle 15 or 30 with drying time. Port needle: CCLG up to two weeks, the bundle every 7 days. Dressing on a healed tunnelled site: CCLG says none is needed and epic3 that one may no longer be required, while CDC calls it an unresolved issue. Strength of chlorhexidine for the skin: CDC above 0.5% in alcohol, epic3 2% in 70% isopropyl alcohol. On the lock, CCLG says saline is sufficient and the Cochrane review could not separate saline from heparin; antimicrobial locks are not routine (epic3 Class D/GPP). CDC suggests them for patients with long-term lines and a history of several line infections despite the best aseptic care (Category II), and SHEA lists them as an additional approach for patients with recurrent infection who are on long-term dialysis lines or have limited venous access, and for those at heightened risk of severe harm from a line infection.
Pediatrics (Rinke et al.) 2012 · Pediatrics (Bundy et al., Children's Hospital Association Hematology/Oncology CLABSI Collaborative) 2014 · Pediatrics (Rinke et al.) 2013 · Children's Cancer and Leukaemia Group (CCLG) 2026 · CDC/HICPAC 2011 · SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 · Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014 · Cochrane Database of Systematic Reviews (Bradford, Edwards, Chan) 2020
Where it differs: Locks the line or port with heparinised saline after the saline flush. CCLG reports that most UK centres no longer do this: "Most centres do not lock line with Heparin nowadays as saline locks are sufficient to maintain patency." The Cochrane review describes a typical lock for children as 1 to 3 ml of heparin 10 units per ml in a tunnelled line and 5 ml of 100 units per ml in a port. The Australian pilot trial used sodium heparin 50 units in 5 ml, 1 to 2 ml per lumen, for tunnelled lines and PICCs, and 2 ml of 100 units per ml for ports.
Evidence: The Cochrane review (2020, 4 trials, 255 infants and children with long-term central lines) found the evidence too uncertain to say which is better: rate ratio for blockage with saline against heparin 0.75 (95% CI 0.10 to 5.51, very low certainty) and for bloodstream infection 1.48 (0.24 to 9.37, low certainty). Its four trials each used a different heparin concentration. A pilot randomised trial in 61 children with cancer (Ullman 2022) saw complete blockage in 2 lines, both in the heparin group, and was a pilot to test whether a larger trial is feasible. The CLOCK trial in seven hospitals in Australia and New Zealand is randomising children with cancer between saline, heparinised saline and a tetrasodium EDTA lock.
Children's Cancer and Leukaemia Group (CCLG) 2026 · Cochrane Database of Systematic Reviews (Bradford, Edwards, Chan) 2020 · Cancer Nursing (Ullman et al.) 2022 · BMJ Open (Ullman et al.) 2024
Where it differs: Fills the line with 70% ethanol for a few hours, to prevent infection or alongside antibiotics to treat one, instead of a heparin or saline lock.
Evidence: For prevention, a multi-centre randomised double-blind trial in 307 children aged 1 to 18 with new lines (Schoot 2015) found line infection in 10% with two-hour ethanol locks (1.5 or 3 ml, at most once a week) against 19% with heparin locks of 100 units per ml (0.77 against 1.46 per 1,000 catheter days, p = 0.039), with more short-lived nausea and taste change. For treatment and secondary prevention, a randomised double-blind trial in 94 children and young people with a new line infection (Wolf 2018) found treatment failure in 44% with ethanol and 43% with placebo, and blockage needing a clot-dissolving drug in 58% against 33%; its authors do not recommend routine use. SHEA says the adverse effects of ethanol locks should be weighed carefully before use.
European Journal of Cancer (Schoot et al.) 2015 · Lancet Infectious Diseases (Wolf et al.) 2018 · SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022
Where it differs: Locks the line with a taurolidine solution, usually with citrate and sometimes heparin, to prevent infection.
Evidence: The trials disagree. A randomised trial of 129 tunnelled lines in 112 children with cancer (Handrup 2013) found catheter-related bloodstream infection at 0.4 per 1,000 line days with taurolidine against 1.4 with heparin (incidence rate ratio 0.26, 95% CI 0.09 to 0.61). The larger CATERPILLAR trial in the Netherlands (463 children, first 90 days after insertion) found line infection in 9.1% with taurolidine, citrate and heparin against 11.2% with heparin alone (incidence rate ratio 0.81, 95% CI 0.46 to 1.45) and concluded that no difference was detected. A 2026 meta-analysis of studies in children (not only cancer) pooled a lower infection rate with taurolidine and said the evidence is insufficient to establish its safety or to recommend routine use.
Pediatric Blood and Cancer (Handrup, Møller, Schrøder) 2013 · Journal of Hospital Infection (van den Bosch et al.) 2024 · Frontiers in Pharmacology (Qin et al.) 2026
Where it differs: Places a chlorhexidine disc or gel dressing around the exit site under the clear dressing. CCLG reports the practice: "Many centres use a BioPatch™ (a chlorhexidine impregnated disc) around the exit site before applying the transparent dressing."
Evidence: The guidelines differ for children. SHEA 2022 lists chlorhexidine-containing dressings for patients over 2 months of age as an essential practice (quality of evidence high) and says their use under 2 months remains unclear. CDC's July 2017 update says no recommendation can be made for patients under 18 because of the lack of sufficient evidence, and says they are not recommended in premature neonates because of the risk of serious skin reactions. CDC's statements are about short-term, non-tunnelled lines; SHEA's is about central lines in general, and SHEA adds that for long-term catheters in well-healed sites the benefit is unclear. No source read makes a recommendation specific to a child's tunnelled line.
Children's Cancer and Leukaemia Group (CCLG) 2026 · SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 · CDC/HICPAC 2011
Where it differs: CCLG: "The needle can stay in place for up to two weeks before being changed and a clear dressing is used to cover and support the needle." The Children's Hospital Association bundle changes the needle every 7 days, sooner if it is soiled, loosened, dislodged or infiltrated. The adult port record notes weekly needle change as common local practice.
Evidence: CCLG cites no study for its interval, the bundle's 7 days is the association's expert consensus, and none of CDC/HICPAC 2011, SHEA 2022 or epic3 sets one.
Children's Cancer and Leukaemia Group (CCLG) 2026 · Pediatrics (Rinke et al.) 2012 · CDC/HICPAC 2011 · SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 · Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014
Where it differs: The Children's Hospital Association bundle asks the person changing a cap, tubing, dressing or port needle, and any assistant, to wear sterile gloves and a mask, and asks for the child's face (or tracheostomy) to be shielded from the site during dressing and port needle changes. The CCLG resource does not mention either.
Evidence: The bundle's authors mark these two elements as expert consensus of the Children's Hospital Association, not as CDC recommendations. The centre that published the bundle did not use sterile gloves and masks for cap and tubing changes, because of the resources needed, and wore clean gloves instead. The bundle was tested as a whole, so the effect of the mask or the shielding on its own is not known.
Pediatrics (Rinke et al.) 2012 · Pediatrics (Rinke et al.) 2013 · Children's Cancer and Leukaemia Group (CCLG) 2026
Where it differs: Washes the child every day with 2% chlorhexidine cloths to lower the number of germs on the skin.
Evidence: SHEA recommends it for intensive care patients over 2 months of age and says its role elsewhere is unclear. The Children's Oncology Group randomised double-blind trial in children with cancer or having a donor stem cell transplant (aged 2 months to under 22 years) stopped early for slow recruitment with 177 enrolled: line infections were 5.44 per 1,000 line days with chlorhexidine and 3.10 with control cloths (p = 0.049), and its authors concluded the data do not support routine use.
SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 · Cancer (Zerr et al.) 2021
Where it differs: Some home parenteral nutrition programmes surveyed for a 2014 review allowed children with a tunnelled line to swim, most of them only in pools, with the site cleaned and the dressing changed straight afterwards. CCLG does not, and advises showers over baths: "Patients with Hickman™ lines are unable to go swimming".
Evidence: A questionnaire and record review of 91 children with cancer and 101 tunnelled lines (Robbins 1999) found no statistically significant difference in line infections between the 49 who swam and those who did not (relative risk 1.6, p = 0.16). A 2014 review reanalysed those figures as a significant excess in swimmers, found no trial, surveyed home parenteral nutrition programmes whose rules ranged from no swimming to no restriction, and concluded that a firm recommendation cannot be made; its authors discourage swimming after a fatal infection in a child in their care. CDC's rule against submerging a catheter is Category IB and is not specific to healed tunnelled lines.
Children's Cancer and Leukaemia Group (CCLG) 2026 · Journal of Pediatric Oncology Nursing (Robbins, Cromwell, Korones) 1999 · Nutrition in Clinical Practice (Miller et al.) 2014 · CDC/HICPAC 2011
Children with a tunnelled central line, which comes out through the skin of the chest, are usually told not to swim for the months or years the line is in. The rule rests on caution: the one study in children with cancer, from 1999, was small and was not a trial. A prospective study could tell families whether swimming in a clean pool with a healed, covered line is safe, and under what conditions.
| Recommendation | Grade, as printed | Source |
|---|---|---|
| Hand hygiene before and after accessing or dressing an intravascular catheter | Category IB | CDC/HICPAC 2011 |
| Chlorhexidine above 0.5% with alcohol for skin preparation during dressing changes | Category IA | CDC/HICPAC 2011 |
| 2% chlorhexidine gluconate in 70% isopropyl alcohol to clean the central line site at dressing changes, left to air dry (a guideline whose scope excludes children on chemotherapy through long-term lines) “to clean the central catheter insertion site during dressing changes, and allow to air dry.” | Class A | Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014 |
| Chlorhexidine in infants under 2 months: no recommendation “No recommendation can be made for the safety or efficacy of chlorhexidine in infants aged <2 months.” | Unresolved issue | CDC/HICPAC 2011 |
| Chlorhexidine-containing dressings for central lines in patients over 2 months of age “Use chlorhexidine-containing dressings for CVCs in patients over 2 months of age (Quality of Evidence: HIGH)” | Quality of Evidence: HIGH | SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 |
| Chlorhexidine dressings under 2 months of age “For children under 2 months of age, use of chlorhexidine dressings remains unclear, particularly in very preterm or low birthweight infants.” | Stated as unclear | SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 |
| Chlorhexidine-impregnated dressings on short-term, non-tunnelled central lines in patients under 18 years: no recommendation (July 2017 update) “No recommendation can be made about the use of chlorhexidine-impregnated dressings to protect the site of short-term, non-tunneled central venous catheters for pediatric patients less than 18 years old and non-premature neonates due to the lack of sufficient evidence from published, high-quality studies about efficacy and safety in this age group.” | Unresolved issue | CDC/HICPAC 2011 |
| Chlorhexidine-impregnated dressings on short-term, non-tunnelled central lines in premature neonates: not recommended (July 2017 update) | Category IC | CDC/HICPAC 2011 |
| Transparent dressings changed at least every 7 days, with a stated exception for children at risk of the line dislodging (written for short-term lines) “except in those pediatric patients in which the risk for dislodging the catheter may outweigh the benefit of changing the dressing” | Category IB | CDC/HICPAC 2011 |
| Transparent dressings on tunnelled or implanted sites changed no more than once a week until the site has healed “Replace transparent dressings used on tunneled or implanted CVC sites no more than once per week (unless the dressing is soiled or loose), until the insertion site has healed.” | Category II | CDC/HICPAC 2011 |
| Dressings on tunnelled or implanted sites replaced every 7 days until healed; a dressing may not be needed after that “A dressing may no longer be required once the insertion site has healed.” | Class D/GPP | Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014 |
| Whether a well-healed tunnelled exit site needs any dressing “No recommendation can be made regarding the necessity for any dressing on well-healed exit sites of long-term cuffed and tunneled CVCs.” | Unresolved issue | CDC/HICPAC 2011 |
| Do not submerge the catheter or its site in water; showering with an impermeable cover is permitted | Category IB | CDC/HICPAC 2011 |
| Scrub the access port with an appropriate antiseptic (chlorhexidine, povidone iodine, an iodophor or 70% alcohol); no time is set | Category IA | CDC/HICPAC 2011 |
| Disinfect hubs, connectors and ports before access, with friction for at least 5 seconds “Apply mechanical friction for a minimum of 5 seconds to reduce contamination.” | Quality of Evidence: MODERATE | SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 |
| Hub cleaned for at least 15 seconds and allowed to dry “The hub should be cleaned for a minimum of 15 s and allowed to dry before accessing the system.” | Class D/GPP | Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014 |
| Antimicrobial lock solutions not used routinely “Antimicrobial lock solutions should not be used routinely to prevent catheter-related bloodstream infections.” | Class D/GPP | Journal of Hospital Infection (Loveday et al., commissioned by the Department of Health) 2014 |
| Prophylactic antimicrobial lock for patients with long-term catheters and a history of multiple catheter-related bloodstream infections despite optimal aseptic technique | Category II | CDC/HICPAC 2011 |
| Antimicrobial lock therapy for long-term lines, as an additional approach where infection recurs “Use antimicrobial lock therapy for long-term CVCs (Quality of Evidence: HIGH)” | Quality of Evidence: HIGH | SHEA, IDSA, APIC (Infection Control and Hospital Epidemiology) 2022 |
| Saline against heparin flushing in children: blockage “The estimated RR for CVC occlusion per 1000 catheter days between the normal saline and heparin groups was 0.75 (95% CI 0.10 to 5.51; 2 studies, 229 participants; very low certainty evidence).” | very low certainty evidence | Cochrane Database of Systematic Reviews (Bradford, Edwards, Chan) 2020 |
| Chlorhexidine bathing in children with cancer or having a donor transplant “The data from the current study do not support the use of routine CHG bathing in children with cancer or those undergoing allogeneic HCT.” | Randomised double-blind trial, stopped early (177 enrolled) | Cancer (Zerr et al.) 2021 |
| A standard line care bundle across 32 children's haematology and oncology units “As of August 2012, the mean CLABSI rate during the collaborative was 2.04 CLABSIs per 1000 CL-days, a reduction of 28% (relative risk: 0.71 [95% confidence interval: 0.55-0.92]).” | Multicentre quality improvement collaborative | Pediatrics (Bundy et al., Children's Hospital Association Hematology/Oncology CLABSI Collaborative) 2014 |
| Swimming with a central line “Unfortunately, due to the limited information available, a firm recommendation cannot be made.” | Narrative review; no trial found | Nutrition in Clinical Practice (Miller et al.) 2014 |
Shares Central line maintenance bundle: preventing bloodstream infection after insertion, Implanted port access, flushing and care in adults having cancer treatment, Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line) and the tags protocol, vascular-access, clabsi.
Shares Fever and neutropenia in children with cancer or after stem cell transplant, Children's Oncology Group (COG), Childhood cancers (all types) and the tags protocol, paediatric.
Shares Fever and neutropenia in children with cancer or after stem cell transplant, Febrile neutropenia, Children's Oncology Group (COG), Childhood cancers (all types) and the tags protocol, paediatric.
Shares Ethanol lock therapy for central venous catheters, Catheter lock solutions (heparin, taurolidine and DefenCath), Tunnelled cuffed central venous catheters (Hickman-type lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports).
Shares Central line maintenance bundle: preventing bloodstream infection after insertion, Febrile neutropenia, Children's Oncology Group (COG), Childhood cancers (all types) and the tags protocol, paediatric.
Shares Central line and port care in the community and at home, Suspected central line infection in a person with cancer: paired blood cultures, first antibiotics and line removal or salvage, PICC and tunnelled central line care: dressing, hub cleaning, flushing and living with the line, Implanted port access, flushing and care in adults having cancer treatment.
Shares Central line maintenance bundle: preventing bloodstream infection after insertion, Procedural pain and sedation for children with cancer: needles, lumbar punctures and marrow tests, Central venous access (port, PICC line), Children's Oncology Group (COG) and the tag protocol.
Shares Procedural pain and sedation for children with cancer: needles, lumbar punctures and marrow tests, Children's Oncology Group (COG), Childhood cancers (all types) and the tags protocol, paediatric.